152 related articles for article (PubMed ID: 37637227)
1. Machine Learning Methods for Endocrine Disrupting Potential Identification Based on Single-Cell Data.
Aghayev Z; Szafran AT; Tran A; Ganesh HS; Stossi F; Zhou L; Mancini MA; Pistikopoulos EN; Beykal B
Chem Eng Sci; 2023 Nov; 281():. PubMed ID: 37637227
[TBL] [Abstract][Full Text] [Related]
2. Predicting the Estrogen Receptor Activity of Environmental Chemicals by Single-Cell Image Analysis and Data-driven Modeling.
Ganesh HS; Beykal B; Szafran AT; Stossi F; Zhou L; Mancini MA; Pistikopoulos EN
ESCAPE; 2021; 50():481-486. PubMed ID: 34355221
[TBL] [Abstract][Full Text] [Related]
3. Classification of estrogenic compounds by coupling high content analysis and machine learning algorithms.
Mukherjee R; Beykal B; Szafran AT; Onel M; Stossi F; Mancini MG; Lloyd D; Wright FA; Zhou L; Mancini MA; Pistikopoulos EN
PLoS Comput Biol; 2020 Sep; 16(9):e1008191. PubMed ID: 32970665
[TBL] [Abstract][Full Text] [Related]
4. Binary Classification of the Endocrine Disrupting Chemicals by Artificial Neural Networks.
Aghayev Z; Walker GF; Iseri F; Ali M; Szafran AT; Stossi F; Mancini MA; Pistikopoulos EN; Beykal B
ESCAPE; 2023; 52():2631-2636. PubMed ID: 37575176
[TBL] [Abstract][Full Text] [Related]
5. Binary classification of a large collection of environmental chemicals from estrogen receptor assays by quantitative structure-activity relationship and machine learning methods.
Zang Q; Rotroff DM; Judson RS
J Chem Inf Model; 2013 Dec; 53(12):3244-61. PubMed ID: 24279462
[TBL] [Abstract][Full Text] [Related]
6. Moving Toward Integrating Gene Expression Profiling Into High-Throughput Testing: A Gene Expression Biomarker Accurately Predicts Estrogen Receptor α Modulation in a Microarray Compendium.
Ryan N; Chorley B; Tice RR; Judson R; Corton JC
Toxicol Sci; 2016 May; 151(1):88-103. PubMed ID: 26865669
[TBL] [Abstract][Full Text] [Related]
7. A ternary classification using machine learning methods of distinct estrogen receptor activities within a large collection of environmental chemicals.
Zhang Q; Yan L; Wu Y; Ji L; Chen Y; Zhao M; Dong X
Sci Total Environ; 2017 Feb; 580():1268-1275. PubMed ID: 28011018
[TBL] [Abstract][Full Text] [Related]
8. In silico identification and pharmacological evaluation of novel endocrine disrupting chemicals that act via the ligand-binding domain of the estrogen receptor α.
McRobb FM; Kufareva I; Abagyan R
Toxicol Sci; 2014 Sep; 141(1):188-97. PubMed ID: 24928891
[TBL] [Abstract][Full Text] [Related]
9. Development, validation and integration of in silico models to identify androgen active chemicals.
Manganelli S; Roncaglioni A; Mansouri K; Judson RS; Benfenati E; Manganaro A; Ruiz P
Chemosphere; 2019 Apr; 220():204-215. PubMed ID: 30584954
[TBL] [Abstract][Full Text] [Related]
10. Identification of potential endocrine disrupting chemicals using gene expression biomarkers.
Corton JC; Kleinstreuer NC; Judson RS
Toxicol Appl Pharmacol; 2019 Oct; 380():114683. PubMed ID: 31325560
[TBL] [Abstract][Full Text] [Related]
11. Can Predictive Modeling Tools Identify Patients at High Risk of Prolonged Opioid Use After ACL Reconstruction?
Anderson AB; Grazal CF; Balazs GC; Potter BK; Dickens JF; Forsberg JA
Clin Orthop Relat Res; 2020 Jul; 478(7):0-1618. PubMed ID: 32282466
[TBL] [Abstract][Full Text] [Related]
12. Computational modeling approaches for developing a synergistic effect prediction model of estrogen agonistic activity.
Seo M; Choi J; Park J; Yu WJ; Kim S
Chemosphere; 2024 Feb; 349():140926. PubMed ID: 38092168
[TBL] [Abstract][Full Text] [Related]
13. An In vitro dimerization assay for the adverse outcome pathway approach in risk assessment of human estrogen receptor α-mediated endocrine-disrupting chemicals.
Lee SH; Seo H; Seo H; Lazari M; D'Agostino M; Byrd N; Yoon KS; Lee HS; Park Y
Chemosphere; 2022 Mar; 290():133267. PubMed ID: 34914963
[TBL] [Abstract][Full Text] [Related]
14. Estrogen Receptor β as a Possible Double-Edged Sword Molecule in Breast Cancer: A Mechanism of Alteration of Its Role by Exposure to Endocrine-Disrupting Chemicals.
Hirao-Suzuki M
Biol Pharm Bull; 2021; 44(11):1594-1597. PubMed ID: 34719637
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of an imaging-based in vitro screening platform for estrogenic activity with OECD reference chemicals.
Duijndam B; Tedeschi M; van der Stel W; van den Hoorn T; van der Burg B; Bouwman P; van der Laan JW; van de Water B
Toxicol In Vitro; 2022 Jun; 81():105348. PubMed ID: 35307500
[TBL] [Abstract][Full Text] [Related]
16. Differential estrogenic actions of endocrine-disrupting chemicals bisphenol A, bisphenol AF, and zearalenone through estrogen receptor α and β in vitro.
Li Y; Burns KA; Arao Y; Luh CJ; Korach KS
Environ Health Perspect; 2012 Jul; 120(7):1029-35. PubMed ID: 22494775
[TBL] [Abstract][Full Text] [Related]
17. Novel machine learning models to predict endocrine disruption activity for high-throughput chemical screening.
Collins SP; Barton-Maclaren TS
Front Toxicol; 2022; 4():981928. PubMed ID: 36204696
[TBL] [Abstract][Full Text] [Related]
18. Is exposure to environmental or industrial endocrine disrupting estrogen-like chemicals able to cause genomic instability?
Roy D; Colerangle JB; Singh KP
Front Biosci; 1998 Aug; 3():d913-21. PubMed ID: 9696883
[TBL] [Abstract][Full Text] [Related]
19. Predicting hepatotoxicity using ToxCast in vitro bioactivity and chemical structure.
Liu J; Mansouri K; Judson RS; Martin MT; Hong H; Chen M; Xu X; Thomas RS; Shah I
Chem Res Toxicol; 2015 Apr; 28(4):738-51. PubMed ID: 25697799
[TBL] [Abstract][Full Text] [Related]
20. In Silico Study of In Vitro GPCR Assays by QSAR Modeling.
Mansouri K; Judson RS
Methods Mol Biol; 2016; 1425():361-81. PubMed ID: 27311474
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
